Classification and measurement of financial assets and derivative financial instruments for banks

Contents

What are financial assets?


 

Use the quick links below to access specific components, solutions and related publications.

   
Linked components  Linked components  
 
  Linked publicatons  Linked publications    
   
  Linked solutions  Linked solutions    
   
A financial asset is any asset that is:

a) cash;
b)

an equity instrument of another entity;

c) a contractual right:
  (i) to receive cash or another financial asset from another entity; or
  (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or
d) a contract that will or may be settled in the entity's own shares and is:
  (i) a non-derivative for which the entity may receive a variable number of its own shares; or
  (ii) a derivative that may be settled other than by the exchange of a fixed amount of cash for a fixed number of its own shares. For this purpose the entity's own shares do not include instruments that are themselves contracts for the future receipt or delivery of the entity's own shares [IAS32R.11].

The definition of financial assets therefore includes, cash, deposits at central and other banks, bills, securities, loans and advances and derivatives with a positive fair value .

There are several exclusions from the normal classification and accounting rules for financial assets. The items excluded are:

a) a hedged item in a fair value hedge [IAS39R.89] ;
b) interests in subsidiaries, associates and joint ventures, except where IAS 27, 28 or 31 requires them to be accounted for under IAS 39 [IAS39R.2(a)];
c) rights and obligations under leases, except for embedded derivatives included in lease contracts [IAS39R.2(b)];
d) employers' assets and liabilities under employee benefit plans [IAS39R.2(c)];
e) rights and obligations under an insurance contract as defined in IFRS 4 Insurance Contracts or under a contract that is within the scope of IFRS 4 because it contains a discretionary participation feature [IAS39R.2(e)] ;
f) financial instruments issued by the entity that meet the definition of an equity instrument in IAS 32 (including options and warrants). The holder of such equity instruments applies IAS 39 to those instruments, unless they meet the exception in (a) above [IAS39R.2(d)];
g) contracts for contingent consideration in a business combination. This exemption applies only to the acquirer [IAS39R.2(f)];
h) contracts between an acquirer and a vendor in a business combination to buy or sell an acquiree at a future date [IAS39R.2(g)];
i) financial instruments, contracts and obligations under share based payment transactions, except for contracts that can be settled net in cash or another financial instrument [IAS39R.2(i)]; and
j) loan commitments that cannot be settled net in cash and which the entity has not designated as at fair value through profit or loss [IAS39R.2(h)].


Classification and its importance


All financial assets, including derivatives, are recognised on the balance sheet under IFRS . They are initially measured at fair value plus, in the case of a financial asset not at fair value through profit or loss, transaction costs that are directly attributable to the acquisition of the asset [IAS39R.43] . The accounting treatment of financial assets, subsequent to initial recognition, depends on how they are classified.

An entity should recognise a financial asset on its balance sheet, when, and only when, it becomes a party to the contractual provisions of the instrument [IAS39R.14] . The purchase or sale of a financial asset in accordance with the time frame generally established by market convention (a 'regular way' transaction), should be recognised using either trade date or settlement date accounting [IAS39R.38] [IAS39R.IG.D.2.2.]. The method used should be applied consistently for all transactions that belong in the same category of financial assets [IAS39R.AG53-54] .

Most financial assets, subsequent to initial recognition, are re-measured to fair value at each balance sheet date. There are two classes of assets that are carried at amortised cost subject to a test for impairment. These are loans and receivables and held-to-maturity investments. There is also an exception to the fair value measurement requirement for investments in equity instruments that do not have a quoted market price in an active market that cannot be reliably measured and for derivatives that are linked to and must be settled by delivery of such unquoted equity instruments. These instruments are measured at cost, subject to a test for impairment. This exception is expected to be used rarely - in most cases an entity will be able to reliably measure the fair value of unquoted equity instruments and derivatives on them [IAS39R.46] .


Categories of financial assets


There are four categories of financial assets: fair value through profit or loss (which includes trading), loans and receivables, held-to-maturity and -sale [IAS39R.45]. All financial assets not covered in the exclusions in section 80.1 above, must be classified into one of the four categories. Classification is not necessarily a free choice but is based on facts and circumstances and the intent of management at the date of purchase. Transfers between categories after initial recognition are restricted.


Financial assets at fair value through profit or loss


A financial asset at fair value through profit or loss is one that either

a) is classified as held for trading, which means that it is
    (i) acquired principally for the purpose of selling it in the near term ;
    (ii) part of a portfolio of identified financial instruments that are managed together and for which there is evidence of a recent actual pattern of short-term profit-taking; or
    (iii) a derivative (except for one that is designated and effecting hedging instrument); or
b) upon initial recognition it is designated as at fair value through profit or loss. An entity may use this designation when doing so results in more relevant information, because either
    (i) it eliminates or significantly reduces a measurement or recognition inconsistency (an 'accounting mismatch') that would otherwise arise from measuring assets or liabilities or recognising the gains and losses on them on different bases; or
    (ii) a group of financial assets and/or financial liabilities is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy and information about the assets and/ or liabilities is provided internally to the entity's key management personnel (as defined in IAS 24).

An entity may also use this designation for a contract that contains one or more embedded derivatives, unless;

(a) that embedded derivative does not significantly modify the cash flows that otherwise would be required by the contract, or
(b) it is clear with little or no analysis that separation of the embedded derivative is prohibited.

Subsequent measurement
Financial assets at fair value through profit or loss are re-measured to fair value at each subsequent balance sheet date until the assets are de-recognised [IAS39R.46] . The gains and losses arising from changes in fair value are included in the income statement in the period in which they occur [IAS39R.55] . Gains and losses will include both realised gains and losses arising on the disposal of these financial assets and unrealised gains and losses arising from changes in the fair value of the assets still held.


Loans and receivables


Loans and receivables are financial assets with fixed or determinable payments that are not quoted in an active market, that are not intended for trading, that are not initially designated as available for sale or where the holder may not recover substantially all of its initial investment other than because of credit deterioration (e.g. interest only strip) .

An interest acquired in a pool of assets that are not loans or receivables (for example, an interest in a mutual fund or a similar fund) is not a loan or receivable [IAS39R.9] .

Loan origination fees and costs
Loan origination fees are deferred and recognised as an adjustment to the effective yield of a loan [IAS18Appendix.14(a)(i)]. A portfolio basis can be adopted if it is not possible to adjust the effective yield on an individual loan basis.

Origination fees are an integral part of generating an ongoing involvement with the resultant financial asset, and together with the related direct costs, are deferred and recognised as an adjustment to the effective yield, except when the financial asset is classified as at fair value through profit or loss [IAS18Appendix.14(a)(i)].

Loan origination costs attributable to unsuccessful loans are expensed. An entity should therefore have a system for distinguishing successful from unsuccessful loans and for determining the related incremental and directly attributable origination costs.

Transaction costs are incremental costs that are directly attributable to the acquisition of a financial asset [IAS39R.9] and include costs such as fees and commissions paid to agents, advisers, brokers and dealers; levies by regulatory agencies and securities exchanges; and transfer taxes and duties. Transaction costs do not include debt premium or discounts, financing costs, or internal administrative or holding costs [IAS39R.AG13] .

Subsequent measurement
Loans and receivables are subsequently measured at amortised cost using the effective interest method, and are subject to impairment testing [IAS39R.46].

Amortised cost is assumed to approximate the original invoice amount for short-term receivables with no stated interest rate if the impact of discounting would not be significant [IAS39R.AG79].

The effective interest method is a method of calculating the amortised cost of a financial asset and of allocating the interest income over the relevant period.

The effective interest rate is the rate that exactly discounts estimated future cash receipts through the expected life of the asset or, when appropriate, a shorter period to its net carrying amount. When calculating the effective interest rate, an entity estimates cash flows considering all contractual terms of the financial instrument (for example, prepayment, call and similar options) but does not consider future credit losses [IAS39R.9].

Entities are not permitted to use an expected life that is longer than the contractual life of the asset when determining the effective interest rate as that would take future credit losses (due to time value) into consideration [IAS39R.9].

Some prepayment penalty fees are included in the effective interest rate. Where a fee is charged in order to compensate the lender for the increased margin that would have been earned had the loan continued to the end of the period during which a penalty must be paid, this is considered as part of the effective interest calculation.

Where the penalty fees are included in the calculation of effective interest and thus in the amortised cost balance, the prepayment option will be closely related to the loan and is not separated as an embedded derivative. This is because the amortised cost balance will always approximate the amount to be repaid if the prepayment option is exercised [IAS39R.AG30(g)].

The expected life of the loan is generally used to determine the effective interest rate. The effective interest calculation is a method of spreading any fees, costs, premiums or discounts over the asset's expected life. However, effective interest calculations do not change the nature of fixed and floating contract terms of loans. For example, when a fixed rate loan reverts to a standard variable rate before the end of its expected life, fees and costs are spread over this expected life, but the effective interest calculation does not blend fixed and floating rate cash flows to produce a single combined effective interest rate. When the interest rate changes from fixed to floating, it impacts the calculation of interest income at that time as the effective interest rate will change. Therefore interest changes are not anticipated by recalculating effective interest rates .


Held-to-maturity investment


Held-to-maturity investments are financial assets with fixed or determinable payments and fixed maturity that an entity has the positive intention and ability to hold to maturity [IAS39R.9] . Fixed or determinable payments and fixed maturity means a contractual arrangement that defines the amounts and dates of payments to the holder, such as interest and principal payments on debt [IAS39R.AG17]. Floating rate debt is considered to have determinable payments and can therefore be included in the held-to-maturity category [IAS39R.AG17].

Held-to-maturity is a restrictive category because it is an exception from the general requirement to measure financial assets at fair value. There are strict criteria that an asset and the entity must meet before assets can be categorised as held-to-maturity.

IFRS requires 'a positive intent and ability' to hold a financial asset to maturity. The intent and ability must be assessed when an asset is acquired and at each subsequent balance sheet date [IAS39R.AG25] . A positive intent to hold the assets is a much higher hurdle than the absence of intent to sell the asset.

Positive intent cannot be demonstrated if [IAS39R.AG16]:

a) the entity intends to hold the financial asset for an undefined period;
b) the entity stands ready to sell the financial asset in response to changes in market interest rates or risks, liquidity needs, changes in the availability of and the yield on alternative investments, changes in financing sources or terms, or changes in foreign currency risk; or
c) the issuer has a right to settle the financial asset at an amount significantly below its amortised cost.

The ability to hold the financial asset to maturity cannot be demonstrated if the entity [IAS39R.AG23]:

a) does not have the financial resources available to continue to finance the investment until maturity ; or
b) is subject to legal or other constraints that could frustrate its intention to hold the financial asset to maturity.

Tainting of held-to-maturity
When an entity's actions cast doubt on its intent or ability to hold investments to maturity, the entity is prohibited from using the held-to-maturity category for a reasonable period of time [IAS39R.AG20] . A penalty is therefore effectively imposed for a change in management's intention. The entity is forced to reclassify all its held-to-maturity investments as -sale and measure them at fair value until it is able, through subsequent actions, to restore faith in its intentions (i.e. "cleansed") [IAS39R.IG.B.19].

More specifically, an entity shall not classify any financial assets as held to maturity if it has, during the current financial year or the two preceding financial years sold or reclassified more than an insignificant amount of held-to-maturity investment before maturity. However, this tainting does not occur if the sales are: (a) so close to maturity that changes in the market rate of interest would not have a significant effect on the financial asset's fair value; (b) occur after the entity has collected substantially all of the asset's original principal; or (c) are attributable to an isolated event that is beyond the entity's control, is non-recurring and could not have been reasonably anticipated by the entity [IAS39R.9].

Tainting affects all assets in the held-to-maturity category. Segregation of assets into separate portfolios does not 'protect' assets held in other portfolios [IAS39R.IG.B.20]. Similarly, holding assets in different legal entities within one group does not prevent the tainting of assets held by other entities. Sale of any held-to-maturity assets will call into question management's intention and ability to hold all assets to maturity not just assets of a similar type or within the same portfolio [IAS39R.9] .

Subsequent measurement
Held-to-maturity assets are subsequently carried [IAS39.46].


Available-for-sale assets


Available-for-sale (AFS) financial assets are those financial assets that are designated as available for sale or are not classified as (a) loans and receivables, (b) held-to-maturity investments or (c) financial assets at fair value through profit or loss [IAS39R.9]. Thus, AFS is a residual category. The AFS category will include all equity securities except those classified as fair value through profit or loss.

Subsequent measurement
Available-for-sale financial assets are carried at fair value subsequent to initial recognition [IAS39R.46]. There is a presumption that fair value can be readily determined for most financial assets either by reference to an active market or by a reasonable estimation process. The only exemption to this is equity securities that do not have a quoted market price in an active market and for which a reliable fair value cannot be reliably measured. .

Most gains or losses on an available-for-sale financial asset shall be recognised directly in equity until the financial asset is derecognised. The cumulative gain or loss previously recognised in equity is recognised in profit or loss when the asset is derecognised. However, impairment losses, foreign exchange gains and losses (on AFS debt securities) and interest (on AFS debt investments) calculated using the effective interest method are recognised in profit or loss. Dividends on an available-for-sale equity instrument are recognised in profit or loss when the entity's right to receive payment is established [IAS39R.55].


Changes in classification of financial assets


Reclassifications between categories are relatively uncommon in IAS 39 and are prohibited into and out of the fair value through profit or loss category, with the exception of the following:

a) derivatives that become part of a hedging relationship and are therefore reclassified out of held-for-trading;
b) derivatives that are no longer part of a hedging relationship and are therefore reclassified into held-for-trading; and
c) a portfolio of assets on which there is evidence that short-term profit-taking has begun, which should be reclassified into held-for-trading.

The most common reason for a reclassification out of the HTM category is when the whole category is tainted and has to be reclassified as available-for-sale for two years. In such circumstances the assets are re-measured to fair value with any difference recognised in equity.

An instrument may be reclassified into the HTM category where the tainted held-to-maturity portfolio has been "cleansed". In this case the financial asset's carrying value at the date of reclassification is recharacterised as amortised cost. Any unrealised gains and losses recognised in equity remain in equity until the asset is impaired or derecognised .


Fair value measurement considerations


All assets classified at fair value through profit or loss (including all derivatives) and available for sale are measured at fair value. Unquoted equity investments and derivatives on unquoted equity investments whose fair value cannot be reliably measured are not measured at fair value. IAS 39 defines fair value as the amount for which an asset could be exchanged or a liability settled, between knowledgeable, willing parties in an arm's length transaction [IAS39R.9].

The presumption that an entity is a going concern without any intention or need to liquidate, or to undertake a transaction on adverse terms underpins the definition of fair value. Fair value is not therefore the amount that an entity would receive or pay in a forced transaction, involuntary liquidation or distress sale. However, fair value does reflect the credit quality of the instrument.

There is a general presumption that fair value can be reliably measured for all financial instruments. IAS 39R provides the following hierarchy for determining an instrument's fair value:

Active market - quoted market price: The existence of published price quotations in an active market is the best evidence of fair value and, when they are available, they must be used to measure fair value . The phrase "quoted in an active market" means that quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service or regulatory agency. Those prices represent actual and regularly occurring market transactions on an arm's length basis. The price can be taken from the most favourable market readily available to the entity even if that was not the market in which a transaction would occur [IAS39R.AG71]. The quoted market price cannot be adjusted for "blockage" or "liquidity" factors. The fair value of a portfolio of financial instruments is the product of the number of units of each instrument and its quoted market prices. The appropriate quoted market price for an asset held or a liability to be issued is the current bid price and for an asset to be acquired or liability held, is the asking price. When an entity has assets and liabilities with offsetting risk positions, it may use mid-market prices and apply the bid or asking price to the net open position as appropriate. When current bid prices are unavailable, the price of the most recent transaction provides evidence of the current fair value [IAS39R.AG72].

No active market - valuation techniques: If the market for a financial instrument is not active, fair value is established by using a valuation technique. The objective of a valuation technique is to establish what the transaction price would have been on the measurement date in an arm's length transaction motivated by normal business considerations [IAS39R.AG75]. Valuation techniques that are well established in financial markets include reference to a transaction that is substantially the same with adjustment for the differences, discounted cash flows and option pricing models. An acceptable valuation technique incorporates all factors that market participants would consider in setting a price, and should be consistent with accepted economic methodologies for pricing financial instruments. Entities are also required to periodically calibrate the valuation technique and test it for validity using prices from any observable current market transactions in the same instrument or based on any available observable market data. An entity obtains market data consistently in the same market where the instrument was originated or purchased [IAS39R.AG76]. Normally the amount paid or received for a financial instrument is the best estimate of fair value at inception. However, where all data inputs to a valuation technique are obtained from observable market transactions, the resulting calculation of fair value can be used for initial recognition .

No active market - equity instruments: Normally it is possible to estimate the fair value of an equity instrument that an entity has acquired from an outside party. However, if the range of reasonable fair value estimates is significant, and no reliable estimate can be made, an entity is permitted, as a last resort, to measure the instrument at cost less impairment. A similar dispensation applies to derivative financial instruments that can only be settled by physical delivery of such unquoted equity instruments.

Day 1 profit recognition: It might be possible in some circumstances to recognise a gain on initial recognition of a financial instrument. However, the circumstances in which this is permitted are very tightly controlled. Entities will have to demonstrate that the fair value is evidenced by actual current market transactions in the same instrument (i.e. without modification or repackaging) or based on a valuation technique whose variables include only observable market data .


Presentation and Disclosure


An entity must disclose the accounting policies and methods adopted, including the criteria for recognition and the basis of measurement applied [IAS32R.60] .

In the notes to the financial statements an entity must also disclose the information required by IAS 32R.51-94 including the following:

a) risk management and hedging policies [IAS32R.56]
b) information about the extent and nature of the financial instruments including any significant terms and conditions [IAS32R.60]
c) information about its exposure to interest rate risk including contractual repricing or maturity dates, whichever dates are earlier and effective interest rates [IAS32R.67]
d) information about its exposure to credit risk including the amount that best represents the maximum credit risk exposure and significant concentrations of credit risk [IAS32R.76]
e) fair values for those financial assets not already measured at fair value [IAS32R.87]
f) methods and significant assumptions applied in determining fair values of all financial assets [IAS32R.92]
g) details of derecognition transactions that either fail to qualify for derecognition or are accounted for using the continuing involvement approach[IAS32R.94(a)]
h) details of collateral pledged and accepted [IAS32R.94(b)]
i) details of compound financial instruments with multiple embedded derivatives [IAS32.94(d)]
j) details about financial assets and financial liabilities designated at fair value through profit or loss [IAS32R.94(e)-(f)]
k) reasons for reclassification of assets measured at cost or amortised cost from fair value [IAS32R.94(g)]
l) material items of income and expense and gains and losses from financial assets [IAS32R.94(h)]
m) nature and amount of any impairment losses [IAS32R.94(i)]




© 2006-2008 PricewaterhouseCoopers. All rights reserved. PricewaterhouseCoopers refers to the network of member firms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity.
Accessibility information Skip navigation Countries online